381
Views
0
CrossRef citations to date
0
Altmetric
Review

Management of hypertension in older people

, , &
Pages 181-191 | Received 05 Apr 2018, Accepted 12 Jul 2018, Published online: 23 Jul 2018

References

  • Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–223.
  • Danaei G, Finucane MM, Lin JK, et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants. Lancet. 2011;377:568–577.
  • Berrut G, Andrieu S, De Carvalho I A, et al. Promoting access to innovation for frail old persons. IAGG (International Association of Gerontology and Geriatrics), WHO (World Health Organization) and SFGG (Societe Francaise de Geriatrie et de Gerontologie) Workshop-Athens. J Nutr Health Aging. 2012 [Jan 20–21];17:688–693.
  • Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA. 2002;287:1003–1010.
  • Krause T, Lovibond K, Caulfield M, et al. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:d4891.
  • Lloyd-Sherlock P, Beard J, Minicuci N, et al. Hypertension among older adults in low and middle-income countries: prevalence, awareness and control. Int J Epidemiol. 2014;43:116–128.
  • Mozaffarian D, Benjamin EJ, Go AS, et al. American heart association statistics committee and stroke statistics subcommittee. heart disease and stroke statistics—2015 update: a report from the american heart association. Circulation. 2015;131:e29–e322.
  • Bromfield SG, Bowling CB, Tanner RM, et al. Trends in hypertension prevalence, awareness, treatment, and control among us adults 80 years and older, 1988–2010. J Clin Hypertens(Greenwich). 2014;16:270–276.
  • National Center for Health Statistics (US). Health, United States. With chart book on trends in the health of Americans. Hyattsville, MD,US: National Center for Health Statistics; 2007.
  • Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588–2605.
  • Mitchell GF,Arterial Stiffness and Hypertension. Hypertension. 2014;64:13–18.
  • Zubcevic J, Jun JY, Kim S, et al. Altered inflammatory response is associated with an impaired autonomic input to the bone marrow in the spontaneously hypertensive rat. Hypertension. 2014;63:542–550.
  • Walsh T, Donnelly T, Lyons D. Impaired endothelial nitric oxide bioavailability: a common link between aging, hypertension and atherogenesis? J Am Geriatr Soc. 2009;57:140–145.
  • Ferreira I, Beijers HJ, Schouten F, et al. Clustering of metabolic syndrome traits is associated with maladaptive carotid remodeling and stiffening: a 6-year longitudinal study. Hypertension. 2012;60:542–549.
  • Fliser D, Ritz E. Relationship between hypertension and renal function and its therapeutic implications in the elderly. Gerontology. 1998;44:123–131.
  • Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American society of hypertension and the international society of hypertension. J Clin Hypertens. (Greenwich). 2014;16:14–26.
  • Mancia G, Fagard R, Narkiewicz K, et al. ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(1281–1357):2013.
  • Whelton PK, Carey RM, Aronow WS, et al. ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/american heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2017. DOI:10.1016/j.jacc.2017.11.006.
  • Safar H, Chahwakilian A, Boudali Y, et al. Arterial stiffness, isolated systolic hypertension, and cardiovascular risk in the elderly. Am J Geriatr Cardiol. 2006;15:178–182.
  • Yavuz BB, Yavuz B, Tayfur O, et al. White coat effect and its clinical implications in the elderly. Clin Exp Hypertens. 2009;31:306–315.
  • Cacciolati C, Hanon O, Alpérovitch A, et al. Masked hypertension in the elderly: cross-sectional analysis of a population-based sample. Am J Hypertens. 2011;24:674–680.
  • James PA, Oparil S, Carter BL, et al. evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(507–520):2014.
  • Spence JD. Pseudo-hypertension in the elderly: still hazy, after all these years. J Hum Hypertens. 1997;11:621–623.
  • Applegate WB, Davis BR, Black HR, et al. Prevalence of postural hypotension at baseline in the Systolic Hypertension in the Elderly Program (SHEP) cohort. J Am Geriatr Soc. 1991;39:1057–1064.
  • Holt-Lunstad J, Jones BQ, Birmingham W. The influence of close relationships on nocturnal blood pressure dipping. Int J Psychophysiol. 2009;71:211–217.
  • Bundy JD, Li C, Stuchlik P, et al. Systolic blood pressure re‐ duction and risk of cardiovascular disease and mortality: a systematic review and network meta‐analysis. JAMA Cardiol. 2017;2:775‐781.
  • Forouzanfar MH, Liu P, Roth GA, et al. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990–2015. JAMA. 2017;317:165–182.
  • Ruixing Y, Weixiong L, Hanjun Y, et al. Diet, lifestyle, and blood pressure of the middle-aged and elderly in the Guangxi Bai Ku Yao and Han populations. Am J Hypertens. 2008;21:382–387.
  • Faselis C, Doumas M, Pittaras A, et al. Exercise Capacity and All-Cause Mortality in Male Veterans With Hypertension Aged ≥70 Years. Hypertension. 2014;64:30–35.
  • Aburto NJ, Ziolkovska A, Hooper L, et al. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ. 2013;346(f1326). DOI:10.1136/bmj.f1326
  • Blood Pressure Lowering Treatment Trialists’ Collaboration. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials. BMJ. 2013;347:f5680.
  • Thomopoulosa C, Paratib G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs-Overview and meta-analyses. J Hypertens. 2015;33:195–211.
  • Palmer SC, Mavridis D, Navarese E, et al. Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis. Lancet. 2015;385:2047–2056.
  • Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957–967.
  • Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years. a randomized clinical trial. JAMA. 2016;315:2673–2682.
  • Xie X, Atkins E, Lv J, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2016;387:435–443.
  • Beckett NS, Peters R, Fletcher AE. Treatment of Hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–1898.
  • Yano Y, Rakugi H, Bakris GL, et al. On-Treatment blood pressure and cardiovascular outcomes in older adults with isolated systolic hypertension. Hypertension. 2017;69:220–227.
  • Saito I, Kario K, Kushiro T, et al. Home blood pressure and cardiovascular outcomes in very elderly patients receiving antihypertensive drug therapy: a subgroup analysis of home blood pressure measurement with olmesartan naive patients to establish standard target blood pressure (HONEST) study. Clin Exp Hypertens. 2018;40:407–413.
  • Thomopoulos C, Parati G, Alberto Z. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 13 – benefits and adverse events in older and younger patients with hypertension overviewmeta-analyses and meta-regression analyses of randomized trials. J Hypertens. 2018;36:1622–1636.
  • Bejan-Angoulvant T, Saadatian-Elahi M, Wright JM, et al. Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials. J Hypertens. 2010;28:1366–1372.
  • Lewington S, Clarke R, Qizilbash N, et al. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 1903–1913;360:2002.
  • Zanchetti A, Thomopoulos C, Parati G. randomized controlled trials of blood pressure lowering in hypertension. A critical reappraisal. Circ Res. 2015;116:1058–1073.
  • Sundström J, Arima H, Jackson R, et al. Effects of blood pressure reduction in mild hypertension. A systematic review and meta-analysis. Ann Intern Med. 2015;162:184–191.
  • Tinetti ME, Han L, Lee DSH, et al. Antihypertensive medications and serious fall injuries in a nationally representative sample of older adults. JAMA Intern Med. 2014;174:588–595.
  • Callisaya L, Sharman JE, Close J, et al. Greater daily defined dose of antihypertensive medication increases the risk of falls in older people—a population-based study. J Am Geriatr Soc. 2014;62:1527–1533.
  • Corrao G, Mazzola P, Monzio Compagnoni M, et al. Antihypertensive medications, loop diuretics, and risk of hip fracture in the elderly: a population-based cohort study of 81,617 Italian patients newly treated between 2005 and 2009. Drugs Aging. 2015;32:927–936.
  • Butt DA, Mamdani M, Austin PC, et al. The risk of hip fracture after initiating antihypertensive drugs in the elderly. Arch Intern Med. 2012;172:1739–1744.
  • Barnes DE, Cauley JA, Lui LY, et al. Women who maintain optimal cognitive function into old age. J Am Geriatr Soc. 2007;55:259–264.
  • Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol. 2011;10:819–828.
  • Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005;4:487–499.
  • Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352:1347–1351.
  • Tzourio C, Anderson C, Chapman N, et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003;163:1069–1075.
  • Lithell H, Hansson L, Skoog I, et al. The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization. J Hypertens Engl. 2004;22:1605–1612.
  • Peters R, Beckett N, Forette F, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol. 2008;7:683–689.
  • Di Bari M, Pahor M, Franse LV, et al. Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. Am J Epidemiol. 2001;153:72–78.
  • Beishon LC, Harrison JK, Harwood RH, et al. The evidence for treating hypertension in older people with dementia: a systematic review. J Hum Hypertens. 2014;28:283–287.
  • Sabayan B, Oleksik AM, Maier AB, et al. High blood pressure and resilience to physical and cognitive decline in the oldest old: the Leiden 85-plus Study. J Am Geriatr Soc. 2012;60:2014–2019.
  • Qiu C, Winblad B, Fratiglioni L. Low diastolic pressure and risk of dementia in very old people: a longitudinal study. Dement Geriatr Cogn Disord. 2009;28:213–219.
  • Ogliari G, Westendorp RG, Muller M, et al. Blood pressure and 10-year mortality risk in the Milan Geriatrics 75+ Cohort Study: role of functional and cognitive status. Age Ageing. 2015;44:932–937.
  • Mossello E, Pieraccioli M, Nesti N, et al. Effects of Low Blood Pressure in Cognitively Impaired Elderly Patients Treated With Antihypertensive Drugs. JAMA Intern Med. 2015;175:578–585.
  • Warwick J, Falaschetti E, Rockwood K, et al. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a double-blind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med. 2015;13(78). DOI:10.1186/s12916-015-0328-1
  • Van Bemmel T, Gussekloo J, Westendorp RG, et al. In a population based prospective study, no association between high blood pressure and mortality after age 85 years. J Hypertens. 2006;24:287–292.
  • Poortvliet RK, Blom JW, De Craen AJ, et al. Low blood pressure predicts increased mortality in very old age even without heart failure: the Leiden 85-plus Study. Eur J Heart Fail. 2013;15:528–533.
  • Poortvliet RK, De Ruijter W, De Craen AJ, et al. Blood pressure trends and mortality: the Leiden 85-plus Study. J Hypertens. 2013;31:63–70.
  • Mattila K, Haavisto M, Rajala S, et al. Blood pressure and five year survival in the very old. BMJ (Clin Res Ed). 1988;296:887–889.
  • Satish S, Freeman DH Jr, Ray L, et al. The relationship between blood pressure and mortality in the oldest old. J Am Geriatr Soc. 2001;49:367–374.
  • Odden MC, Peralta CA, Haan MN, et al. Rethinking the association of high blood pressure with mortality in elderly adults: the impact of frailty. Arch Intern Med. 2012;172:1162–1168.
  • Franklin SS, Jacobs MJ, Wong ND, et al. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives. Hypertension. 2001;37:869–874.
  • Denardo SJ, Gong Y, Nichols WW, et al. Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy. Am J Med. 2010;123:719–726.
  • Räihä I, Luutonen S, Piha J, et al. Prevalence, predisposing factors, and prognostic importance of postural hypotension. Arch Intern Med. 1995;155:930–935.
  • Ricci F, Fedorowski A, Radico F, et al. Cardiovascular morbidity and mortality related to orthostatic hypotension: a meta-analysis of prospective observational studies. Eur Heart J. 2015;36:1609–1617.
  • Gangavati A, Hajjar I, Quach L, et al. Hypertension, orthostatic hypotension, and the risk of falls in a community-dwelling elderly population: the maintenance of balance, independent living, intellect, and zest in the elderly of Boston study. J Am Geriatr Soc. 2011;59:383–389.
  • Benetos A, Labat C, Rossignol P, et al. Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents. The PARTAGE Study. JAMA Intern Med. 2015;175:989–995.
  • Rajpura J, Nayak R. Medication adherence in a sample of elderly suffering from hypertension: evaluating the influence of illness perceptions, treatment beliefs, and illness burden. J Manag Care Pharm. 2014;20:58–65.
  • Banach M, Aronow WS. Blood pressure J-curve: current concepts. Curr Hypertens Rep. 2012;14:556–566.
  • Benetos A, Gautier S, Labat C, et al. Mortality and cardiovascular events are best predicted by low central/peripheral pulse pressure amplification but not by high blood pressure levels in elderly nursing home subjects: the PARTAGE (Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Population) study. J Am Coll Cardiol. 2012;60:1503–1511.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.